Revenue: The sum of all revenue fields included for a company's operating activities.
Tenaya Therapeutics, Inc. (TNYA) had Revenue of $0.23M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
|
Revenue |
$0.23M |
$-19.27M |
|
-- |
|
$0.23M |
|
$20.29M |
|
$-20.07M |
|
$0.79M |
|
$-19.27M |
|
$-19.27M |
|
$-19.27M |
|
$-19.27M |
|
$-19.27M |
|
$-19.27M |
|
$-20.07M |
|
$-18.30M |
|
216.88M |
|
216.88M |
|
$-0.09 |
|
$-0.09 |
|
| Balance Sheet Financials | |
$96.56M |
|
$25.96M |
|
$38.51M |
|
$135.07M |
|
$16.78M |
|
-- |
|
$12.10M |
|
$28.88M |
|
$106.19M |
|
$106.19M |
|
$106.19M |
|
217.00M |
|
| Cash Flow Statement Financials | |
$-19.23M |
|
$-0.01M |
|
$-0.41M |
|
$100.97M |
|
$81.31M |
|
$-19.66M |
|
$2.20M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.75 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-8917.78% |
|
-8917.78% |
|
-- |
|
-8565.33% |
|
-8565.33% |
|
$-19.25M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
0.02 |
|
4250.80 |
|
-18.15% |
|
-18.15% |
|
-14.27% |
|
-18.15% |
|
$0.49 |
|
$-0.09 |
|
$-0.09 |
|